Logo image of TAC

TRANSALTA CORP (TAC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TAC - CA89346D1078 - Common Stock

12.37 USD
+0.17 (+1.39%)
Last: 1/9/2026, 8:29:04 PM
12.9575 USD
+0.59 (+4.75%)
After Hours: 1/9/2026, 8:29:04 PM
Fundamental Rating

4

Overall TAC gets a fundamental rating of 4 out of 10. We evaluated TAC against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. While TAC is still in line with the averages on profitability rating, there are concerns on its financial health. TAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TAC was profitable.
TAC had a positive operating cash flow in the past year.
In multiple years TAC reported negative net income over the last 5 years.
In the past 5 years TAC always reported a positive cash flow from operatings.
TAC Yearly Net Income VS EBIT VS OCF VS FCFTAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

The Return On Assets of TAC (-2.17%) is worse than 65.00% of its industry peers.
The Return On Equity of TAC (-12.58%) is worse than 65.00% of its industry peers.
TAC has a Return On Invested Capital (2.51%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for TAC is above the industry average of 4.09%.
The 3 year average ROIC (8.64%) for TAC is well above the current ROIC(2.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.17%
ROE -12.58%
ROIC 2.51%
ROA(3y)3.11%
ROA(5y)-0.07%
ROE(3y)17.47%
ROE(5y)0.34%
ROIC(3y)8.64%
ROIC(5y)N/A
TAC Yearly ROA, ROE, ROICTAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

In the last couple of years the Profit Margin of TAC has grown nicely.
TAC has a worse Operating Margin (8.62%) than 60.00% of its industry peers.
In the last couple of years the Operating Margin of TAC has grown nicely.
The Gross Margin of TAC (83.57%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of TAC has remained more or less at the same level.
Industry RankSector Rank
OM 8.62%
PM (TTM) N/A
GM 83.57%
OM growth 3Y15.27%
OM growth 5Y8.46%
PM growth 3YN/A
PM growth 5Y22.94%
GM growth 3Y3.39%
GM growth 5Y-0.46%
TAC Yearly Profit, Operating, Gross MarginsTAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TAC is still creating some value.
Compared to 1 year ago, TAC has less shares outstanding
Compared to 5 years ago, TAC has more shares outstanding
Compared to 1 year ago, TAC has an improved debt to assets ratio.
TAC Yearly Shares OutstandingTAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TAC Yearly Total Debt VS Total AssetsTAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that TAC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.30, TAC is doing worse than 60.00% of the companies in the same industry.
TAC has a debt to FCF ratio of 12.69. This is a negative value and a sign of low solvency as TAC would need 12.69 years to pay back of all of its debts.
TAC has a Debt to FCF ratio of 12.69. This is in the better half of the industry: TAC outperforms 80.00% of its industry peers.
A Debt/Equity ratio of 2.28 is on the high side and indicates that TAC has dependencies on debt financing.
TAC has a Debt to Equity ratio (2.28) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF 12.69
Altman-Z 0.3
ROIC/WACC0.36
WACC6.97%
TAC Yearly LT Debt VS Equity VS FCFTAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

TAC has a Current Ratio of 0.79. This is a bad value and indicates that TAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.79, TAC is in line with its industry, outperforming 55.00% of the companies in the same industry.
A Quick Ratio of 0.71 indicates that TAC may have some problems paying its short term obligations.
TAC's Quick ratio of 0.71 is in line compared to the rest of the industry. TAC outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.71
TAC Yearly Current Assets VS Current LiabilitesTAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

TAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.16%.
Measured over the past years, TAC shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.80% on average per year.
The Revenue for TAC has decreased by -11.00% in the past year. This is quite bad
TAC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)-92.16%
EPS 3YN/A
EPS 5Y26.8%
EPS Q2Q%83.33%
Revenue 1Y (TTM)-11%
Revenue growth 3Y1.5%
Revenue growth 5Y3.92%
Sales Q2Q%-3.04%

3.2 Future

Based on estimates for the next years, TAC will show a very strong growth in Earnings Per Share. The EPS will grow by 22.27% on average per year.
The Revenue is expected to decrease by -1.63% on average over the next years.
EPS Next Y-76.78%
EPS Next 2Y-14.26%
EPS Next 3Y-9.5%
EPS Next 5Y22.27%
Revenue Next Year-7.03%
Revenue Next 2Y-11.68%
Revenue Next 3Y-7.04%
Revenue Next 5Y-1.63%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TAC Yearly Revenue VS EstimatesTAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TAC Yearly EPS VS EstimatesTAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 412.33, TAC can be considered very expensive at the moment.
TAC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of TAC to the average of the S&P500 Index (27.19), we can say TAC is valued expensively.
The Price/Forward Earnings ratio is 41.65, which means the current valuation is very expensive for TAC.
TAC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TAC is cheaper than 65.00% of the companies in the same industry.
TAC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 412.33
Fwd PE 41.65
TAC Price Earnings VS Forward Price EarningsTAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

TAC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TAC is cheaper than 75.00% of the companies in the same industry.
TAC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TAC is cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.62
EV/EBITDA 11.3
TAC Per share dataTAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

TAC's earnings are expected to decrease with -9.50% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)15.39
EPS Next 2Y-14.26%
EPS Next 3Y-9.5%

4

5. Dividend

5.1 Amount

TAC has a Yearly Dividend Yield of 1.54%.
In the last 3 months the price of TAC has falen by -20.65%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 1.42, TAC pays a bit more dividend than its industry peers.
TAC's Dividend Yield is slightly below the S&P500 average, which is at 1.94.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

On average, the dividend of TAC grows each year by 6.10%, which is quite nice.
TAC has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of TAC decreased in the last 3 years.
Dividend Growth(5Y)6.1%
Div Incr Years2
Div Non Decr Years2
TAC Yearly Dividends per shareTAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

TAC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of TAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-64.77%
EPS Next 2Y-14.26%
EPS Next 3Y-9.5%
TAC Yearly Income VS Free CF VS DividendTAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

TRANSALTA CORP

NYSE:TAC (1/9/2026, 8:29:04 PM)

After market: 12.9575 +0.59 (+4.75%)

12.37

+0.17 (+1.39%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-18 2026-02-18/bmo
Inst Owners75.64%
Inst Owner Change0%
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap3.67B
Revenue(TTM)2.48B
Net Income(TTM)-193.00M
Analysts78.89
Price Target17.24 (39.37%)
Short Float %1.11%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.29
Dividend Growth(5Y)6.1%
DP-64.77%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-27 2026-02-27 (0.065)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-30.35%
Min EPS beat(2)-116.39%
Max EPS beat(2)55.69%
EPS beat(4)1
Avg EPS beat(4)-161.55%
Min EPS beat(4)-564.33%
Max EPS beat(4)55.69%
EPS beat(8)3
Avg EPS beat(8)-60.42%
EPS beat(12)6
Avg EPS beat(12)2.11%
EPS beat(16)7
Avg EPS beat(16)-18.99%
Revenue beat(2)1
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-14.2%
Max Revenue beat(2)10.93%
Revenue beat(4)3
Avg Revenue beat(4)10.43%
Min Revenue beat(4)-14.2%
Max Revenue beat(4)24.1%
Revenue beat(8)6
Avg Revenue beat(8)16.4%
Revenue beat(12)10
Avg Revenue beat(12)30.69%
Revenue beat(16)14
Avg Revenue beat(16)30.68%
PT rev (1m)4.59%
PT rev (3m)27.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.28%
EPS NY rev (1m)345.64%
EPS NY rev (3m)-21.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 412.33
Fwd PE 41.65
P/S 2.05
P/FCF 14.62
P/OCF 8.08
P/B 3.32
P/tB 6.67
EV/EBITDA 11.3
EPS(TTM)0.03
EY0.24%
EPS(NY)0.3
Fwd EY2.4%
FCF(TTM)0.85
FCFY6.84%
OCF(TTM)1.53
OCFY12.38%
SpS6.04
BVpS3.73
TBVpS1.86
PEG (NY)N/A
PEG (5Y)15.39
Graham Number1.59
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -12.58%
ROCE 3.04%
ROIC 2.51%
ROICexc 2.65%
ROICexgc 3%
OM 8.62%
PM (TTM) N/A
GM 83.57%
FCFM 14.01%
ROA(3y)3.11%
ROA(5y)-0.07%
ROE(3y)17.47%
ROE(5y)0.34%
ROIC(3y)8.64%
ROIC(5y)N/A
ROICexc(3y)9.79%
ROICexc(5y)N/A
ROICexgc(3y)11.08%
ROICexgc(5y)N/A
ROCE(3y)10.46%
ROCE(5y)N/A
ROICexgc growth 3Y15.81%
ROICexgc growth 5Y18.53%
ROICexc growth 3Y15.46%
ROICexc growth 5Y17.81%
OM growth 3Y15.27%
OM growth 5Y8.46%
PM growth 3YN/A
PM growth 5Y22.94%
GM growth 3Y3.39%
GM growth 5Y-0.46%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF 12.69
Debt/EBITDA 4.44
Cap/Depr 49.13%
Cap/Sales 11.35%
Interest Coverage 0.75
Cash Conversion 79.95%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.71
Altman-Z 0.3
F-Score5
WACC6.97%
ROIC/WACC0.36
Cap/Depr(3y)120.63%
Cap/Depr(5y)98.51%
Cap/Sales(3y)23.21%
Cap/Sales(5y)22.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.16%
EPS 3YN/A
EPS 5Y26.8%
EPS Q2Q%83.33%
EPS Next Y-76.78%
EPS Next 2Y-14.26%
EPS Next 3Y-9.5%
EPS Next 5Y22.27%
Revenue 1Y (TTM)-11%
Revenue growth 3Y1.5%
Revenue growth 5Y3.92%
Sales Q2Q%-3.04%
Revenue Next Year-7.03%
Revenue Next 2Y-11.68%
Revenue Next 3Y-7.04%
Revenue Next 5Y-1.63%
EBIT growth 1Y-67.18%
EBIT growth 3Y17%
EBIT growth 5Y12.72%
EBIT Next Year58.24%
EBIT Next 3Y14.67%
EBIT Next 5Y18.16%
FCF growth 1Y-15.94%
FCF growth 3Y-2.47%
FCF growth 5Y2.59%
OCF growth 1Y-58.14%
OCF growth 3Y-7.35%
OCF growth 5Y-1.28%

TRANSALTA CORP / TAC FAQ

What is the ChartMill fundamental rating of TRANSALTA CORP (TAC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TAC.


What is the valuation status of TRANSALTA CORP (TAC) stock?

ChartMill assigns a valuation rating of 3 / 10 to TRANSALTA CORP (TAC). This can be considered as Overvalued.


What is the profitability of TAC stock?

TRANSALTA CORP (TAC) has a profitability rating of 5 / 10.


Can you provide the financial health for TAC stock?

The financial health rating of TRANSALTA CORP (TAC) is 3 / 10.


How sustainable is the dividend of TRANSALTA CORP (TAC) stock?

The dividend rating of TRANSALTA CORP (TAC) is 4 / 10 and the dividend payout ratio is -64.77%.